Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a common drug better protect mothers and babies during C-Sections?

NCT ID NCT05264870

Disease control Sponsor: University Hospital, Antwerp Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at using norepinephrine to treat low blood pressure that often occurs during C-sections done under spinal anesthesia. The goal was to see how the drug affects both the mother and the newborn. Only 11 women participated, and the trial was stopped early, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
norepinephrine
What this could lead to
If successful, this could show that norepinephrine is a safe and effective alternative to phenylephrine for managing blood pressure during C-sections.
What could go wrong
This is a very small, terminated trial with only 11 participants, so results may not be reliable or generalizable. The drug's effects on the newborn are still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

11 people

The number who actually took part.

Started

Jun 2022

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * American Society of Anesthesiologists classification (ASA)1 and 2 patients * non-laboring and singleton pregnancy Exclusion Criteria: * patients with cardiovascular comorbidities * any kind of cardiac and peripheral vascular disease or diabetes * history of coagulopathy * contra-indication to spinal anesthesia * allergic condition to vasopressors or local anesthetics * total body weight under 50kg or above 100kg * length under 150cm and over 180cm Body Mass Index (BM)I ≥ 32

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean section complications Foetal stress Hemodynamic instability

Contacts and locations

Locations

  • Antwerp University Hospital

    Edegem, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.